Paradigm Biopharmaceuticals Ltd
ASX:PAR

Watchlist Manager
Paradigm Biopharmaceuticals Ltd Logo
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Watchlist
Price: 0.32 AUD -4.48% Market Closed
Market Cap: 124.6m AUD

Wall Street
Price Targets

PAR Price Targets Summary
Paradigm Biopharmaceuticals Ltd

Wall Street analysts forecast PAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PAR is 0.82 AUD with a low forecast of 0.81 AUD and a high forecast of 0.84 AUD.

Lowest
Price Target
0.81 AUD
153% Upside
Average
Price Target
0.82 AUD
155% Upside
Highest
Price Target
0.84 AUD
163% Upside
Paradigm Biopharmaceuticals Ltd Competitors:
Price Targets
BCAX
Bicara Therapeutics Inc
282% Upside
MCRB
Seres Therapeutics Inc
432% Upside
6955
Shandong Boan Biotechnology Co Ltd
12% Downside
RAPT
Rapt Therapeutics Inc
263% Upside
CRNX
Crinetics Pharmaceuticals Inc
152% Upside
MSB
Mesoblast Ltd
79% Upside
LXRX
Lexicon Pharmaceuticals Inc
221% Upside
9926
Akeso Inc
17% Upside

Revenue
Forecast

Revenue Estimate
Paradigm Biopharmaceuticals Ltd

For the last 8 years the compound annual growth rate for Paradigm Biopharmaceuticals Ltd's revenue is 21%.

21%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Paradigm Biopharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

Net Income Estimate
Paradigm Biopharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PAR's stock price target?
Price Target
0.82 AUD

According to Wall Street analysts, the average 1-year price target for PAR is 0.82 AUD with a low forecast of 0.81 AUD and a high forecast of 0.84 AUD.

Back to Top